A new oral medication called Foundayo™ (orforglipron) has been approved by the FDA for weight loss and is now available in the United States. This once-daily pill is designed for adults with obesity or those who are overweight and have related medical issues. Unlike other weight loss medications, Foundayo can be taken at any time without food or water restrictions, making it a convenient option for those looking to shed pounds. The starting price is $25 per month for individuals with commercial insurance and $149 for those paying out of pocket.

For people striving to age well and maintain a healthy weight, Foundayo could offer significant benefits. In clinical trials, participants lost an average of 27 pounds (12.4%) when using Foundayo alongside a calorie-restricted diet and increased physical activity, compared to just 2.2 pounds (0.9%) for those on a placebo. Additionally, the medication has been shown to reduce cardiovascular risk markers, such as waist circumference and cholesterol levels, which are critical for long-term health.

The evidence supporting Foundayo comes from large Phase 3 clinical trials involving over 4,500 participants, indicating strong efficacy and safety data. However, while the results are promising, it’s essential to note that the medication is still relatively new, and potential side effects include nausea, diarrhea, and more serious risks like thyroid tumors. Therefore, it’s crucial to consult with a healthcare professional to determine if Foundayo is appropriate for you.

If you’re considering weight loss options, speak with your healthcare provider about Foundayo and other strategies that can support your health goals. Remember, any weight loss plan should ideally include a balanced diet and regular exercise for the best results.

Source: investor.lilly.com